SCHEMBL23487520

SCHEMBL23487520

COc1cccc(C(C)N)c1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
NFKB1 P19838 1/20 0.60
PNMT P11086 1/20 0.60
ALDH1A1 P00352 1/20 0.58
LMNA P02545 1/20 0.58
GLA P06280 1/20 0.58
PDCD1LG2 Q9BQ51 3/20 0.45
CD274 Q9NZQ7 3/20 0.45
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
ACHE P22303 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA1A P35348 1/20 0.41
MEN1 O00255 1/20 0.40
MAPK1 P28482 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
IDO1 P14902 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13913509 0.84 KCNK3 (0.46) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL12061499 0.82 CYP2D6 (0.47) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL19398867 0.82 CYP2D6 (0.47) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL29705638 0.81 CA1 (0.55) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL334556 0.81 CA1 (0.55) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL334379 0.81 CA1 (0.55) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL29471011 0.81 CA1 (0.55) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL1257092 0.81 CA1 (0.55) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL21377269 0.81 CA1 (0.55) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL12094589 0.81 KCNK3 (0.41) CYP2D6CYP1A2CYP3A4ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021110009-A1 NOVEL AURORA KINASE INHIBITOR AND USE THEREOF 微境生物医药科技(上海)有限公司 2021-06-10 WO disclosed